What does CUSIP 604749101 represent in this 13F holders report?

CUSIP 604749101 is the security identifier for MIRM - Mirum Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in Q3 2022?

107 institutional investors reported MIRM - Mirum Pharmaceuticals, Inc. - Common Stock for Q3 2022. Use the holders table for investor-level position and value details.

Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)

CUSIP: 604749101

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Common Stock
Shares outstanding: 60,799,281
Total 13F shares: 33,748,714
Share change: +4,407,293
Total reported value: $709,089,633
Put/Call ratio: 0%
Price per share: $21.01
Number of holders: 107
Value change: +$93,197,315
Number of buys: 63
Number of sells: 40

Quarterly Holders Quick Answers

What is CUSIP 604749101?
CUSIP 604749101 identifies MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 604749101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of MIRM - Mirum Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
James E. Flynn	3/4/5	* Possible Member of 10% Group, 10%+ Owner	— class O/S missing	3,244,434	$90,958,032	—	06 Jun 2022	3/4/5
NEA Management Company, LLC	13F	Company	6.9%	4,187,801	$81,495,000	—	30 Jun 2022	13F
Frazier Life Sciences Management, L.P.	13F	Company	5.9%	3,566,912	$69,412,000	—	30 Jun 2022	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	5.3%	3,244,434	$63,137,000	—	30 Jun 2022	13F
Novo Holdings A/S	13F	Company	3.3%	2,027,324	$37,931,000	—	30 Jun 2022	13F
RiverVest Venture Management LLC	13F	Company	3.2%	1,921,118	$37,385,000	—	30 Jun 2022	13F
Rock Springs Capital Management LP	13F	Company	2.8%	1,717,733	$33,427,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	2.3%	1,396,012	$27,166,000	—	30 Jun 2022	13F
CADIAN CAPITAL MANAGEMENT, LP	13F	Company	2.3%	1,385,997	$26,972,000	—	30 Jun 2022	13F
FRANKLIN RESOURCES INC	13F	Company	2.1%	1,249,122	$24,308,000	—	30 Jun 2022	13F
Polar Capital Holdings Plc	13F	Company	2%	1,212,432	$23,594,000	—	30 Jun 2022	13F
VANGUARD GROUP INC	13F	Company	1.6%	982,975	$19,128,000	—	30 Jun 2022	13F
AXA S.A.	13F	Company	1.5%	886,399	$17,249,325	—	30 Jun 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.71%	429,847	$8,365,000	—	30 Jun 2022	13F
MPM BioImpact LLC	13F	Company	0.47%	288,531	$5,615,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.46%	280,860	$5,465,000	—	30 Jun 2022	13F
ORBIMED ADVISORS LLC	13F	Company	0.46%	279,500	$5,439,000	—	30 Jun 2022	13F
First Light Asset Management, LLC	13F	Company	0.46%	277,674	$5,404,000	—	30 Jun 2022	13F
STATE STREET CORP	13F	Company	0.45%	275,867	$5,368,000	—	30 Jun 2022	13F
Soleus Capital Management, L.P.	13F	Company	0.32%	196,018	$3,815,000	—	30 Jun 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.29%	177,496	$3,454,000	—	30 Jun 2022	13F
Integral Health Asset Management, LLC	13F	Company	0.29%	177,427	$3,453,000	—	30 Jun 2022	13F
NORTHERN TRUST CORP	13F	Company	0.29%	176,766	$3,440,000	—	30 Jun 2022	13F
SILVERCREST ASSET MANAGEMENT GROUP LLC	13F	Company	0.27%	164,387	$3,199,000	—	30 Jun 2022	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.27%	161,920	$3,151,000	—	30 Jun 2022	13F
Prosight Management, LP	13F	Company	0.27%	161,527	$3,143,000	—	30 Jun 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.26%	158,000	$3,075,000	—	30 Jun 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.26%	157,047	$3,056,000	—	30 Jun 2022	13F
MORGAN STANLEY	13F	Company	0.22%	135,665	$2,640,000	—	30 Jun 2022	13F
Highlander Partners, L.P.	13F	Company	0.2%	122,980	$2,393,000	—	30 Jun 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.2%	121,808	$2,370,000	—	30 Jun 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.2%	121,292	$2,360,000	—	30 Jun 2022	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.16%	100,000	$1,946,000	—	30 Jun 2022	13F
Informed Momentum Co LLC	13F	Company	0.16%	95,607	$1,861,000	—	30 Jun 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.13%	80,374	$1,562,000	—	30 Jun 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.13%	76,025	$1,480,000	—	30 Jun 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.12%	74,481	$1,449,000	—	30 Jun 2022	13F
Bank of New York Mellon Corp	13F	Company	0.12%	73,647	$1,433,000	—	30 Jun 2022	13F
Edwin Jonathan Tucker	3/4/5	Chief Medical Officer	— class O/S missing	45,838	$1,285,073	—	10 Nov 2021	3/4/5
Raymond James Financial Services Advisors, Inc.	13F	Company	0.11%	65,819	$1,281,000	—	30 Jun 2022	13F
Palo Alto Investors LP	13F	Company	0.11%	64,700	$1,259,000	—	30 Jun 2022	13F
Global IMC LLC	13F	Company	0.1%	61,233	$1,192,000	—	30 Jun 2022	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.09%	52,560	$1,023,000	—	30 Jun 2022	13F
Jackson Creek Investment Advisors LLC	13F	Company	0.06%	37,356	$938,000	—	30 Jun 2022	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.07%	45,570	$887,000	—	30 Jun 2022	13F
Calamos Advisors LLC	13F	Company	0.07%	42,521	$828,000	—	30 Jun 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.07%	42,511	$828,000	—	30 Jun 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.07%	42,349	$824,000	—	30 Jun 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.07%	41,500	$808,000	—	30 Jun 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.06%	38,803	$756,000	—	30 Jun 2022	13F

Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q3 2022

As of 30 Sep 2022, Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by 107 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,748,714 shares. The largest 10 holders included NEA Management Company, LLC, Frazier Life Sciences Management, L.P., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RiverVest Venture Management LLC, Rock Springs Capital Management LP, BlackRock Inc., Novo Holdings A/S, FRANKLIN RESOURCES INC, CADIAN CAPITAL MANAGEMENT, LP, and EVENTIDE ASSET MANAGEMENT, LLC. This page lists 107 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

104

Q3 2022 holders

107

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.